Byung Jhip Ha
Sam Chun Dang Pharm. Co. Ltd.
2
0
2
N/A
0
5
Research Impact
N/A
Research impact score
0
Total publications
0
Published trial results
0
Total citations
Drug Portfolio
Analytics
Trial Phases
Trial Status
Role Distribution
Activity Timeline
Clinical Trials (2)
Research Network
Collaboration Network
Research Areas & Affiliations
Therapeutic Areas
Affiliations
Similar Key Opinion Leaders
Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.
Shenzhi Liang, Doctor
The First Affiliated Hospital of Zhengzhou University
Shared therapeutic areas:
Shanjun Cai, Doctor
Zunyi Medical College
Shared therapeutic areas:
Xiaolin Liang, Doctor
Sun Yat-sen Ophthalmic Center, Sun Yat-sen University
Shared therapeutic areas:
Lan Li, Master
The First People's Hospital of Kunming
Shared therapeutic areas:
Hongping Cui, Doctor
Shanghai Oriental Hospital
Shared therapeutic areas:
Hongmei Zheng, Doctor
People's Hospital of Wuhan University (Hubei Provincial People's Hospital)
Shared therapeutic areas:
Yaohong Wu, Doctor
Second Hospital of Shanxi Medical University
Shared therapeutic areas:
Liuhua Tong, Doctor
People's Hospital of Quzhou
Shared therapeutic areas:
Gangfeng Cui, Doctor
Taizhou Hospital of Zhejiang Province affiliated to Wenzhou Medical University
Shared therapeutic areas:
Jian Guo, Doctor
First Affiliated Hospital of Fujian Medical University
Shared therapeutic areas:
Publications (0)
No publications found for this investigator.
Clinical Trials (2)
Showing 2 of 2 trials
Study of the SCD411 Prefilled Syringe for Treating Adults With Wet Age-Related Macular Degeneration, Retinal Vein Occlusion, Diabetic Macular Edema, or Diabetic Retinopathy
A Study to Comparing SCD411 and Eylea® in Subjects With Wet Age-related Macular Degeneration (AMD)
All 2 trials loaded